Achema middle east

Tag: Big Pharma

Eli Lilly Becomes the First Drugmaker to Hit $1tn Valuation

Eli Lilly, the US pharma giant, has become the first drugmaker to hit $1tn valuation on November 22, 2025, hence entering the exclusive club,...

400 Global Regulatory Manufacturing Approvals for Samsung Biologics

Samsung Biologics announced on November 26, 2025, that it has gone on to achieve a whopping 400 regulatory manufacturing approvals all over the world due to...

AstraZeneca and Daiichi Report Datroway Efficacy for TNBC

Datroway, a cancer drug developed by AstraZeneca and Daiichi Sankyo, has demonstrated a statistically significant and clinically meaningful improvement for the dual primary endpoints...

Is US Planning Executive Order on Chinese Pharma Companies?

It is worth noting that the pharmaceutical sector’s recent source of novel molecules may as well be coming under threat. Apparently, it is the...

Asia’s Bio Sovereignty: Nations Reclaiming Biologics Control

The biopharmaceutical industry in the Asia-Pacific area has seen a significant strategic shift in recent years; this trend is now commonly acknowledged as Asia's...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »